![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: LUC7L3 |
Gene summary for LUC7L3 |
![]() |
Gene information | Species | Human | Gene symbol | LUC7L3 | Gene ID | 51747 |
Gene name | LUC7 like 3 pre-mRNA splicing factor | |
Gene Alias | CRA | |
Cytomap | 17q21.33 | |
Gene Type | protein-coding | GO ID | GO:0000245 | UniProtAcc | J3KPP4 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
51747 | LUC7L3 | GSM4909286 | Human | Breast | IDC | 1.41e-18 | 4.26e-01 | 0.1081 |
51747 | LUC7L3 | GSM4909294 | Human | Breast | IDC | 2.75e-06 | -2.44e-01 | 0.2022 |
51747 | LUC7L3 | GSM4909296 | Human | Breast | IDC | 6.56e-26 | -4.71e-01 | 0.1524 |
51747 | LUC7L3 | GSM4909297 | Human | Breast | IDC | 2.23e-21 | -2.05e-01 | 0.1517 |
51747 | LUC7L3 | GSM4909298 | Human | Breast | IDC | 2.91e-12 | 4.28e-01 | 0.1551 |
51747 | LUC7L3 | GSM4909301 | Human | Breast | IDC | 1.67e-02 | -1.50e-02 | 0.1577 |
51747 | LUC7L3 | GSM4909304 | Human | Breast | IDC | 1.00e-03 | -3.05e-01 | 0.1636 |
51747 | LUC7L3 | GSM4909309 | Human | Breast | IDC | 1.10e-02 | -1.62e-02 | 0.0483 |
51747 | LUC7L3 | GSM4909311 | Human | Breast | IDC | 5.39e-40 | -5.67e-01 | 0.1534 |
51747 | LUC7L3 | GSM4909312 | Human | Breast | IDC | 6.79e-18 | -3.04e-01 | 0.1552 |
51747 | LUC7L3 | GSM4909313 | Human | Breast | IDC | 1.17e-03 | -2.65e-01 | 0.0391 |
51747 | LUC7L3 | GSM4909315 | Human | Breast | IDC | 7.25e-07 | -3.16e-01 | 0.21 |
51747 | LUC7L3 | GSM4909316 | Human | Breast | IDC | 1.38e-03 | -4.08e-01 | 0.21 |
51747 | LUC7L3 | GSM4909317 | Human | Breast | IDC | 5.22e-03 | 2.80e-01 | 0.1355 |
51747 | LUC7L3 | GSM4909319 | Human | Breast | IDC | 1.58e-53 | -2.88e-01 | 0.1563 |
51747 | LUC7L3 | GSM4909320 | Human | Breast | IDC | 8.07e-08 | -4.95e-01 | 0.1575 |
51747 | LUC7L3 | GSM4909321 | Human | Breast | IDC | 4.72e-27 | -3.42e-01 | 0.1559 |
51747 | LUC7L3 | brca10 | Human | Breast | Precancer | 3.62e-03 | -3.71e-01 | -0.0029 |
51747 | LUC7L3 | M1 | Human | Breast | IDC | 4.13e-17 | 6.13e-01 | 0.1577 |
51747 | LUC7L3 | M2 | Human | Breast | IDC | 3.29e-02 | -1.88e-02 | 0.21 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:002261312 | Liver | Cirrhotic | ribonucleoprotein complex biogenesis | 231/4634 | 463/18723 | 3.28e-32 | 6.86e-29 | 231 |
GO:000037512 | Liver | Cirrhotic | RNA splicing, via transesterification reactions | 175/4634 | 324/18723 | 5.95e-30 | 7.47e-27 | 175 |
GO:000037712 | Liver | Cirrhotic | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 172/4634 | 320/18723 | 4.02e-29 | 3.60e-26 | 172 |
GO:000039812 | Liver | Cirrhotic | mRNA splicing, via spliceosome | 172/4634 | 320/18723 | 4.02e-29 | 3.60e-26 | 172 |
GO:007182612 | Liver | Cirrhotic | ribonucleoprotein complex subunit organization | 115/4634 | 227/18723 | 2.67e-17 | 3.63e-15 | 115 |
GO:002261812 | Liver | Cirrhotic | ribonucleoprotein complex assembly | 112/4634 | 220/18723 | 4.35e-17 | 5.81e-15 | 112 |
GO:00002454 | Liver | Cirrhotic | spliceosomal complex assembly | 34/4634 | 79/18723 | 2.78e-04 | 2.46e-03 | 34 |
GO:00063762 | Liver | Cirrhotic | mRNA splice site selection | 20/4634 | 49/18723 | 9.60e-03 | 4.35e-02 | 20 |
GO:002261322 | Liver | HCC | ribonucleoprotein complex biogenesis | 355/7958 | 463/18723 | 7.76e-52 | 4.92e-48 | 355 |
GO:000838022 | Liver | HCC | RNA splicing | 313/7958 | 434/18723 | 1.36e-36 | 1.73e-33 | 313 |
GO:000037522 | Liver | HCC | RNA splicing, via transesterification reactions | 228/7958 | 324/18723 | 1.47e-24 | 4.06e-22 | 228 |
GO:000037722 | Liver | HCC | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 224/7958 | 320/18723 | 1.16e-23 | 2.62e-21 | 224 |
GO:000039822 | Liver | HCC | mRNA splicing, via spliceosome | 224/7958 | 320/18723 | 1.16e-23 | 2.62e-21 | 224 |
GO:007182622 | Liver | HCC | ribonucleoprotein complex subunit organization | 159/7958 | 227/18723 | 3.14e-17 | 3.06e-15 | 159 |
GO:002261822 | Liver | HCC | ribonucleoprotein complex assembly | 153/7958 | 220/18723 | 3.44e-16 | 2.91e-14 | 153 |
GO:000024511 | Liver | HCC | spliceosomal complex assembly | 46/7958 | 79/18723 | 3.45e-03 | 1.56e-02 | 46 |
GO:00718268 | Lung | IAC | ribonucleoprotein complex subunit organization | 46/2061 | 227/18723 | 3.02e-05 | 7.79e-04 | 46 |
GO:00083808 | Lung | IAC | RNA splicing | 75/2061 | 434/18723 | 4.89e-05 | 1.12e-03 | 75 |
GO:00226188 | Lung | IAC | ribonucleoprotein complex assembly | 44/2061 | 220/18723 | 6.16e-05 | 1.34e-03 | 44 |
GO:00003778 | Lung | IAC | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 52/2061 | 320/18723 | 2.64e-03 | 2.44e-02 | 52 |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
LUC7L3 | SNV | Missense_Mutation | c.685N>C | p.Glu229Gln | p.E229Q | protein_coding | tolerated(0.06) | benign(0.293) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | ||
LUC7L3 | SNV | Missense_Mutation | novel | c.1178N>T | p.Ser393Phe | p.S393F | protein_coding | deleterious_low_confidence(0) | probably_damaging(0.999) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
LUC7L3 | SNV | Missense_Mutation | c.620G>A | p.Arg207Gln | p.R207Q | protein_coding | deleterious(0.04) | probably_damaging(0.979) | TCGA-BH-A0DS-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Chemotherapy | cyclophosphamide | SD | ||
LUC7L3 | deletion | Frame_Shift_Del | c.228delC | p.Phe76LeufsTer2 | p.F76Lfs*2 | protein_coding | TCGA-E9-A248-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cyclophosphamide | SD | ||||
LUC7L3 | SNV | Missense_Mutation | novel | c.1361N>A | p.Ser454Asn | p.S454N | protein_coding | tolerated_low_confidence(0.18) | probably_damaging(0.995) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
LUC7L3 | SNV | Missense_Mutation | c.607G>A | p.Asp203Asn | p.D203N | protein_coding | deleterious(0) | benign(0.019) | TCGA-JW-A5VL-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | ||
LUC7L3 | SNV | Missense_Mutation | c.781N>T | p.Arg261Trp | p.R261W | protein_coding | deleterious(0) | possibly_damaging(0.645) | TCGA-A6-2672-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | ||
LUC7L3 | SNV | Missense_Mutation | c.781C>T | p.Arg261Trp | p.R261W | protein_coding | deleterious(0) | possibly_damaging(0.645) | TCGA-AA-3663-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | ||
LUC7L3 | SNV | Missense_Mutation | novel | c.107N>C | p.Lys36Thr | p.K36T | protein_coding | tolerated(0.31) | possibly_damaging(0.482) | TCGA-AZ-4315-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
LUC7L3 | SNV | Missense_Mutation | c.530N>T | p.Ser177Leu | p.S177L | protein_coding | tolerated(0.13) | probably_damaging(0.979) | TCGA-AG-A002-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |